Results 11 to 20 of about 198,685 (310)
Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations
PURPOSE Mutations in the HRAS (mHRAS) proto-oncogene occur in 4%-8% of patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). Tipifarnib is a farnesyltransferase inhibitor that disrupts HRAS function.
A. Ho +24 more
semanticscholar +1 more source
Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma
Head and neck squamous cell carcinoma (HNSCC), an aggressive malignancy, is characterized by high morbidity and low survival rates with limited therapeutic options outside of regional surgery, conventional cytotoxic chemotherapy, and irradiation ...
Areeg Elmusrati +2 more
semanticscholar +1 more source
Background : /Aims: In head and neck squamous cell carcinoma, second primary gastrointestinal tumors are not uncommon. However, it is unclear whether a screening endoscopy is needed for detecting gastrointestinal neoplasm in patients with head and neck ...
Gyeong Mi Heo +4 more
doaj +1 more source
Human Papilloma Virus (HPV) Induced Head & Neck Squamous Cell Carcinoma: A Comprehensive Retrospect [PDF]
Head and Neck Squamous Cell Carcinoma accounts for the sixth most common malignancy occurring worldwide with tobacco and alcohol being the two well established risk factors.
Roquaiya Nishat +4 more
doaj +1 more source
Head and neck squamous cell carcinoma (HNSCC) is a very aggressive disease with a poor prognosis for advanced-stage tumors. Recent clinical, genomic, and cellular studies have revealed the highly heterogeneous and immunosuppressive nature of HNSCC ...
A. Bhat +11 more
semanticscholar +1 more source
Most of the malignant neoplasms of the head and neck are represented by squamous cell carcinoma. 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography in squamous cell carcinoma of the head and neck is applied for primary ...
О. D. Ryzhova +6 more
doaj +1 more source
Head and neck squamous cell carcinoma
Review on Head and neck squamous cell carcinoma, with data on clinics, and the genes involved.
H. Blons
semanticscholar +1 more source
Clinical Controversy Surrounding the Differential Diagnosis of Branchiogenic Carcinoma
Clinical evaluation, differential diagnosis, and management of a neck mass constitute commonly encountered problems for the head and neck surgeon. An asymptomatic neck mass in adults may be the only clinical sign of head and neck cancer.
Alexander Karatzanis +4 more
doaj +1 more source
The aim of this study was to determine the methylation status of the genes encoding the vascular endothelial growth factor receptors and to evaluate the usefulness of VEGFR methylation as a prognostic indicator in head and neck squamous cell carcinoma ...
Yuki Misawa +10 more
doaj +1 more source
Circulating tumor cells in head and neck cancer: A review
Carcinoma of the head and neck represents 3.5% of all cancers, and the vast majority of these tumors are squamous cell carcinoma (HNSCC). With a stable overall survival rate of 50% among all stages, there is continued interested in developing measures ...
Kyle P. McMullen +4 more
doaj +1 more source

